Mesenteric arterial and venous blood flow changes following selective arterial injections of vasodilators.
D000109:Acetylcholine / Q000008:administration & dosage; D000792:Angiography; D000818:Animals; D001920:Bradykinin / Q000008:administration & dosage; D003973:Diatrizoate / Q000008:administration & dosage; D004285:Dogs; D004600:Eledoisin / Q000008:administration & dosage; D004837:Epinephrine / Q000008:administration & dosage; D005934:Glucagon / Q000008:administration & dosage; D007269:Injections, Intra-Arterial; D008638:Mesenteric Arteries / Q000187:drug effects*; D008642:Mesenteric Veins / Q000187:drug effects*; D010208:Papaverine / Q000008:administration & dosage; D012039:Regional Blood Flow / Q000187:drug effects; D014043:Tolazoline / Q000008:administration & dosage; D014665:Vasodilator Agents / Q000008:administration & dosage*
D014665:Vasodilator Agents; D003973:Diatrizoate; D004600:Eledoisin; D005934:Glucagon; D014043:Tolazoline; D010208:Papaverine; D000109:Acetylcholine; D001920:Bradykinin; D004837:Epinephrine